Candriam SCA’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-130,547
| Closed | -$14.5M | – | 952 |
|
2021
Q1 | $14.5M | Hold |
130,547
| – | – | 0.12% | 188 |
|
2020
Q4 | $15.1M | Buy |
130,547
+22,120
| +20% | +$2.55M | 0.12% | 190 |
|
2020
Q3 | $10.6M | Sell |
108,427
-11,535
| -10% | -$1.12M | 0.1% | 218 |
|
2020
Q2 | $14.7M | Buy |
119,962
+44,151
| +58% | +$5.42M | 0.16% | 163 |
|
2020
Q1 | $7.75M | Hold |
75,811
| – | – | 0.09% | 262 |
|
2019
Q4 | $7.93M | Buy |
75,811
+24,611
| +48% | +$2.57M | 0.09% | 266 |
|
2019
Q3 | $5.89M | Hold |
51,200
| – | – | 0.08% | 284 |
|
2019
Q2 | $8.79M | Buy |
51,200
+10,000
| +24% | +$1.72M | 0.11% | 207 |
|
2019
Q1 | $6.95M | Hold |
41,200
| – | – | 0.09% | 256 |
|
2018
Q4 | $4.01M | Buy |
41,200
+4,580
| +13% | +$446K | 0.06% | 323 |
|
2018
Q3 | $6.33M | Buy |
36,620
+10,700
| +41% | +$1.85M | 0.08% | 274 |
|
2018
Q2 | $3.62M | Buy |
25,920
+2,500
| +11% | +$349K | 0.06% | 360 |
|
2018
Q1 | $2.64M | Buy |
23,420
+420
| +2% | +$47.3K | 0.05% | 416 |
|
2017
Q4 | $3.04M | Sell |
23,000
-6,000
| -21% | -$792K | 0.05% | 376 |
|
2017
Q3 | $2.94M | Buy |
29,000
+5,000
| +21% | +$507K | 0.05% | 374 |
|
2017
Q2 | $2.41M | Buy |
24,000
+7,000
| +41% | +$702K | 0.05% | 429 |
|
2017
Q1 | $2.06M | Buy |
17,000
+3,000
| +21% | +$363K | 0.04% | 438 |
|
2016
Q4 | $1.56M | Buy |
14,000
+3,000
| +27% | +$335K | 0.04% | 416 |
|
2016
Q3 | $1.46M | Sell |
11,000
-5,000
| -31% | -$664K | 0.04% | 421 |
|
2016
Q2 | $1.47M | Buy |
+16,000
| New | +$1.47M | 0.04% | 363 |
|